Medical devices, healthcare technology and the business of care
510(k) clearance · K262652

Electric Wheelchair (CN501)

Zhejiang Shimo Technology Co., Ltd. · Decision date Oct 13, 2026

MEDTECHLEDGER EXPLANATIONK262652

What did the FDA decide?

The FDA recorded a substantially equivalent decision for K262652, an Electric Wheelchair (CN501) submitted by Zhejiang Shimo Technology Co., Ltd. The entry appears in the agency's list of 510(k) final decisions rendered since October 01, 2026, with a publish date of October 13, 2026. The record carries product code ITI and is filed under Physical Medicine.

Substantial equivalence in the 510(k) pathway indicates clearance to market, not premarket approval of a new device. The source data do not identify a predicate device, describe the technological characteristics of the CN501, or state whether the submission covered a changed item relative to a prior clearance. No summary, indications, or review memorandum is present in the public information, so the basis for the equivalence finding remains unknown.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Physical Medicine
Decision date
Oct 13, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K262652
Regulatory pathway
510(k) premarket notification
Product code
ITI
Decision code
SESE
Decision date
Oct 13, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Wheelchair, Powered.

Product code
ITI
FDA device class
2

FDA decision timeline

  1. K262652 received

    Application receipt date recorded by FDA.

  2. K262652 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code ITI

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Zhejiang Shimo Technology Co., Ltd.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Yongkang

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records